期刊文献+

抗人白细胞介素15单克隆抗体的制备及特性鉴定 被引量:2

Preparation and characterization of anti-human IL-15 monoclonal antibody
下载PDF
导出
摘要 目的 :制备鼠抗人白细胞介素 15(hIL 15)单克隆抗体 (mAb) ,并鉴定其特性。方法 :自重组人白细胞介素 15(rhIL 15)基因工程菌中 ,提取融合蛋白GST IL 15,以 12 0g/LSDS PAGE分离鉴定 ,切取含有目的条带的凝胶 ,免疫BALB/c小鼠。取免疫小鼠的脾细胞与Sp2 / 0骨髓瘤细胞常规融合 ,依次进行HAT选择培养 ,间接ELISA法筛选抗体阳性的杂交瘤细胞及克隆化。对杂交瘤细胞株的稳定性及其分泌的mAb的特性进行鉴定。另外 ,以rhIL 15包涵体蛋白 (rhIL 15IBP)免疫新西兰白兔 ,制备抗hIL 15的多克隆抗体 (多抗 )。用抗hIL 15的mAb与多抗建立双抗体夹心间接ELISA。结果 :获得 1株可稳定分泌特异性抗hIL 15mAb的杂交瘤细胞。建立了双抗体夹心间接ELISA ,检测rhIL 15蛋白的敏感性达 10 μg/L。结论 :成功地制备抗hIL 15mAb ,并建立了一种可用于hIL 15检测的双抗体夹心间接ELISA。 AIM: To prepare monoclonal antibody (mAb) against human interleukin-15 (hIL-15) and identify its characterization. METHODS: The GST-I L-15 was extracted from the gene-engineering bacteria E.coli and identifie d by SDS-PAGE. The gel strip containing GST-IL-15 was cut off to immunize BAL B/c mice. The splenocytes of immunized mice were fused with Sp2/0 myeloma cells by a routine method and the hybridomas were selected in HAT medium. The hybridom a cells secreting specific antibody were detected by ELISA and cloned by limitin g dilution. The stability of the obtained hybridoma cells and the specificity o f anti-hIL-15 mAb the hybridoma cells secreted were identified. In addition, t he New Zealand rabbits were immunized with the rhIL-15 inclusion body pr otein (rhIL-15IBP) to prepare the polyclonal antibody (pAb) against hIL- 15. A sandwich ELISA was established with the anti-IL-15 mAb and pAb as coatin g and sandwich antibodies, respectively, to detect hIL-15. RESULTS: One hybridoma cell line which could stably secrete specific mAb was obtaine d. A sandwich ELISA for detecting rhIL-15 protein was established and i ts sensitivity was as low as 10 μg/L. CONCLUSION: The an ti-hIL-15 mAb was prepared successfully. A sandwich ELISA for the detection of hIL-15 was established.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第2期183-185,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 河北省自然科学基金资助 (No .30 2 4 99)
关键词 包涵体蛋白 人IL-15 单克隆抗体 ELISA inclusion body protein human IL-15 monoclonal antibo dy ELISA
  • 相关文献

参考文献5

  • 1Michael S, Wolfgang K, Volker G, et al. Induction of IL-15 mRNAand Protein in A549 Cells by pro-inflammatory cytokines [ J ]. Immunobiology, 1994, 199:14-22.
  • 2Leroy S, Dubois S, Tenaud I, et al. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome )[J]. BrJDermatol, 2001, 144 (5): 1016-1023.
  • 3Yamada Y, Sugawara K, Hata T, et al. Interleukin-15 can replace theIL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell linesexpression of IL-15 receptor alpha on ATL cells [J]. Blood, 1998,91 (11): 4265 -4272.
  • 4Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cellgrowth factor that interacts with the beta chain of the interleukin-2 receptor[J]. Science, 1994, 264:965-968.
  • 5王从印,王润田,陈良,葛锡锐.rhIL-15表达载体的构建及其在大肠杆菌中的表达[J].细胞与分子免疫学杂志,2002,18(4):332-334. 被引量:2

二级参考文献3

共引文献3

同被引文献19

  • 1Pizza M,Bugnoli M,Manetti R,et al.The subunit S1 is important for pertussis toxin secretion[J].J Biol Chem,1990,29(265):17759-17763.
  • 2Friguet B,Chaffotte AF,Goldberg M,et al.Measurements of the true affinity constant in solution of antigen-abtibody complexes by enzyme-linked immunosorbent assay[J].J Immunol Methods,1985,77:305-319.
  • 3Halperin SA,Bortolussi R,Kasina A,et al.Use of Chinese overy cell cytotoxicity assay for the rapid diagnosis of pertussis[J].J Clin Microbiol,1990,28(1):32-38.
  • 4Müller FC,Hoppe JE,Knig CV.Laboratory diagnosis of pertussis:state of the art in 1997[J].J Clin Microbiol,1997,35(10):2435-2443.
  • 5Campins-Martí M,Cheng HK,Forsyth K,et al.Recommendations are needed for adolescent and adult pertussis immunization:rationale and strategies for consideration[J].Vaccine,2001,20:614-646.
  • 6Ranieri G, Gasparini G. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy [ J ]. Curr Drug Targets Immune Endocr Metabol Disord, 2001, 1(3) : 241 -253.
  • 7Dudek AZ, Pawlak WZ, Kirstein MN. Molecular targets in the inhibition of angiogenesis [ J ]. Expert Op in Ther Targets, 2003,7 (4) : 527 -541.
  • 8Mrrjans F, Meyer T, Frrrschen C, et al. In vivo therapy of malignant melanoma by means of antagonists of αv integrins[J]. Int J Cancer, 2000, 87(5) : 716 -723.
  • 9Mancuso A, Sternberg CN. Colorectal cancer and antiangiogenic therapy: What can be expected in clinical practice? [J]. Oncology/Hematology, 2005, 55( 1 ) : 67 -81.
  • 10Reynolds LE, Wyder L, Lively JC, et al. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrin [J]. Nat Med, 2002, 8 ( 1 ) : 27 - 34.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部